Text: H.R.5196 — 116th Congress (2019-2020)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (11/20/2019)

 
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5196 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 5196

   To amend the Federal Election Campaign Act of 1971 to prohibit a 
   separate segregated fund of a corporation which is engaged in the 
  manufacture of opioids from making contributions or expenditures in 
 connection with elections for Federal office, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 20, 2019

   Mr. Delgado (for himself and Mr. Rose of New York) introduced the 
     following bill; which was referred to the Committee on House 
                             Administration

_______________________________________________________________________

                                 A BILL


 
   To amend the Federal Election Campaign Act of 1971 to prohibit a 
   separate segregated fund of a corporation which is engaged in the 
  manufacture of opioids from making contributions or expenditures in 
 connection with elections for Federal office, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Save Lives Act''.

SEC. 2. PROHIBITING CAMPAIGN SPENDING BY SEPARATE SEGREGATED FUNDS OF 
              CORPORATIONS ENGAGED IN MANUFACTURE OF OPIOIDS.

    (a) Prohibition.--Section 316(b) of the Federal Election Campaign 
Act of 1971 (52 U.S.C. 30118(b)) is amended--
            (1) in paragraph (2)(C), by striking ``the establishment'' 
        and inserting ``subject to paragraph (8), the establishment''; 
        and
            (2) by adding at the end the following new paragraph:
    ``(8)(A) A separate segregated fund of a corporation may not 
solicit any contribution, and may not make any contribution or 
expenditure, at any time during which the corporation is engaged in the 
manufacture of opioids.
    ``(B) In this paragraph--
            ``(i) the term `manufacture' has the meaning given such 
        term in section 102(15) of the Controlled Substances Act (21 
        U.S.C. 802(15)); and
            ``(ii) the term `opioid' has the meaning given such term in 
        section 102(18) of the Controlled Substances Act (21 U.S.C. 
        802(18)).''.
    (b) Effective Date.--The amendments made by this section shall 
apply with respect to contributions solicited, and contributions and 
expenditures made, on or after the date of the enactment of this Act.
                                 <all>